HHGA
LABU icon

Halbert Hargrove Global Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Hold
1,000
– – 0.01% 87
2026
Q1 		$166K Buy
+1,000
New +$164K 0.01% 106

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

Halbert Hargrove Global Advisors's LABU Position: Q2 2026 in Review

Halbert Hargrove Global Advisors held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q2 2026 at 1,000 shares worth $292K. The position accounts for 0.01% of the portfolio, ranked #87.

Halbert Hargrove Global Advisors first reported a position in LABU in Q1 2026 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Halbert Hargrove Global Advisors held 1,000 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $292K as of Q2 2026.
  • Halbert Hargrove Global Advisors left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #87 holding.
  • Halbert Hargrove Global Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2026 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.